Cannon-Global-Investment-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-28
Total Holdings
76
Total Value
50302095
Accession Number
0001844427-25-000004
Form Type
13F-HR
Manager Name
Cannon-Global-Investment-Management
Data Enrichment
95% identified
72 identified4 unidentified

Holdings

76 positions • $50.3M total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
Lifevantage Corp
Shares:10.7K
Value:$156.0K
% of Portfolio:0.3% ($156.0K/$50.3M)
Eton Pharmaceuticals, Inc.
Shares:11.4K
Value:$148.0K
% of Portfolio:0.3% ($148.0K/$50.3M)
Emergent BioSolutions Inc.
Shares:29.6K
Value:$143.9K
% of Portfolio:0.3% ($143.9K/$50.3M)
aTYR PHARMA INC
Shares:47.5K
Value:$143.4K
% of Portfolio:0.3% ($143.4K/$50.3M)
ClearPoint Neuro, Inc.
Shares:12.0K
Value:$142.7K
% of Portfolio:0.3% ($142.7K/$50.3M)
eHealth, Inc.
Shares:18.1K
Value:$120.9K
% of Portfolio:0.2% ($120.9K/$50.3M)
Corvus Pharmaceuticals, Inc.
Shares:35.0K
Value:$111.3K
% of Portfolio:0.2% ($111.3K/$50.3M)
Ferroglobe PLC
Shares:26.0K
Value:$96.5K
% of Portfolio:0.2% ($96.5K/$50.3M)
INDIVIOR PLC
Shares:10.0K
Value:$95.3K
% of Portfolio:0.2% ($95.3K/$50.3M)
Amylyx Pharmaceuticals, Inc.
Shares:25.5K
Value:$90.3K
% of Portfolio:0.2% ($90.3K/$50.3M)
MIMEDX GROUP, INC.
Shares:10.0K
Value:$76.0K
% of Portfolio:0.2% ($76.0K/$50.3M)
ABEONA THERAPEUTICS INC.
Shares:14.0K
Value:$66.6K
% of Portfolio:0.1% ($66.6K/$50.3M)
Gevo, Inc.
Shares:50.0K
Value:$58.0K
% of Portfolio:0.1% ($58.0K/$50.3M)
Aclaris Therapeutics, Inc.
Shares:37.4K
Value:$57.2K
% of Portfolio:0.1% ($57.2K/$50.3M)
Eos Energy Enterprises, Inc.
Shares:15.0K
Value:$56.7K
% of Portfolio:0.1% ($56.7K/$50.3M)
Checkpoint Therapeutics, Inc.
Shares:10.0K
Value:$40.4K
% of Portfolio:0.1% ($40.4K/$50.3M)